Search Results

The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer.

• Authors : Larson, Alaina C.^1,2 (AUTHOR); Doty, Kenadie R.^1,2 (AUTHOR); Solheim, Joyce C.^1,2,3,4 (AUTHOR)

• Source: Cancer Medicine. May2024, Vol. 13 Issue 10, p1-17. 17p.

Record details

Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy.

• Authors : Mu-Chun Yang^1,2; Sheng-Kang Chiu^2,3; Jong-Kai Hsiao^2,4

• Source: Journal of Cancer Research & Practice. Jan-Mar2024, Vol. 11 Issue 1, p39-43. 5p.

Record details

Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach.

• Authors : Chen, Chung-Jiah J.¹ (AUTHOR) ; Choi, Michael Y.¹ (AUTHOR) ; Heyman, Benjamin M.² (AUTHOR)

• Source: Cancers. Sep2023, Vol. 15 Issue 18, p4483. 21p.

Record details

Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma.

• Authors : Lee, Dae Ho¹ (AUTHOR); Kim, Hye Ryun² (AUTHOR); Keam, Bhumsuk³ (AUTHOR)

• Source: Cancer Medicine. Aug2023, Vol. 12 Issue 15, p16066-16075. 10p.

Record details

Acute myeloid leukemia in the elderly: evaluation of overall survival in 69 consecutive patients.

• Authors : Veneri D; Zanetti F; Franchini M

Subjects: Aged/Aged/Aged/*physiology ; Aged, 80 and over/Aged, 80 and over/Aged, 80 and over/*physiology ; Leukemia, Myeloid/Leukemia, Myeloid/Leukemia, Myeloid/*mortality

• Source: Haematologica [Haematologica] 2002 Apr; Vol. 87 (4), pp. 447-8.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print Cited Medium: Print ISSN: 0390-6078

Record details

High-Frequency Nanosecond Bleomycin Electrochemotherapy and its Effects on Changes in the Immune System and Survival.

• Authors : Balevičiūtė, Austėja^1,2 (AUTHOR) ; Radzevičiūtė, Eivina² (AUTHOR); Želvys, Augustinas² (AUTHOR)

• Source: Cancers. 12/15/2022, Vol. 14 Issue 24, p6254. 26p.

Record details

EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer

• Authors : Chan, Ann M; Aguirre, Brian; Liu, Lucia

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Immunology

• Source: Cancers. 16(8)

Record details

A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer

• Authors : Shatsky, Rebecca A; Batra-Sharma, Hemali; Helsten, Teresa

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

• Source: Breast Cancer Research. 26(1)

Record details

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

• Authors : López-Guillermo, Armando¹ (AUTHOR); Canales, Miguel Ángel² (AUTHOR); Dlouhy, Ivan¹ (AUTHOR)

• Source: Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p93-100. 8p.

Record details

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

• Authors : Magbanua, Mark Jesus M; Brown Swigart, Lamorna; Ahmed, Ziad

Subjects: Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Immunology

• Source: Cancer Cell. 41(6)

Record details